AU StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Novel Coronavirus Treatment

945.017

-3.557-0.37%

Number of Gainers:7

Number of Losers:9

Number of Flat:17

PE:- -

High:952.966

Open:945.695

Low:941.113

Close:948.574

Volume:21.23M

Turnover:229.30M

Market Cap:232.95B

Float Cap:191.09B

Loading ...

CSL Says Vanguard Group Raises Stake

MT Newswires Live

Biotron Ltd-Change of Share Registry

THOMSON REUTERS

Dimerix Secures AU$34 Million in Non-Dilutive Loan Facility Agreements; Shares Up 4%

MT Newswires Live

Dimerix Ltd - Secures A$34 Mln Non-Dilutive Funding Facility

THOMSON REUTERS

Coles cuts ties with controversial CIA-linked US data giantThe US company’s software underpins American deportation raids and battlefield targeting systems.2 min read

Australian Shares Rise as Miners, Banks Gain on Lower Oil, Bond Yields

BCAL Diagnostics - Requests Removal of Michael Aicher and Appointment of Forrester and Melki to Gss Board

THOMSON REUTERS

ASX Penny Stocks To Watch In September 2026

Simply Wall St.

Australia's Coles Falls on Trading Ex-Dividend

Genetic Signatures - Requested BCAL Diagnostics to Clarify Details of Its Shareholdings and Associates in Gss

THOMSON REUTERS

Black Box Warning on CSL's Injectafer Unlikely to Change Much

Ansell’s Bigger Buyback And Higher Dividend Could Be A Game Changer For Ansell (ASX:ANN)

Simply Wall St.

Is ResMed (RMD) Below Fair Value On The MatrixCare Sale?

Simply Wall St.

CSL Bulls Don't See Large Impact from U.S. Pricing Deals

Dimerix - Trading Halt Requested Pending Announcement on Non-Dilutive Funding Arrangements

THOMSON REUTERS

ResMed Launches $450 Million Accelerated Share Buyback With Citibank

MT Newswires Live

Here's Why We're Not Too Worried About AnteoTech's (ASX:ADO) Cash Burn Situation

Simply Wall St.

ResMed to Buy Back $450M in Stock Under Accelerated Share Repurchase Agreement

IDT (IDT) Heads To The Midwest IDEAS Conference, Is It Still 9% Undervalued?

Simply Wall St.

Australia's Consumer Stocks Lag in August Earnings Season, Jefferies Says

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.imtigers.com/stock/BK7501/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"BK7501","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK7501\",,,,,undefined,":{"symbol":"BK7501","market":"AU","secType":"PLATE","nameCN":"Novel Coronavirus Treatment","latestPrice":945.0165,"timestamp":1789106399882,"preClose":948.57355,"halted":0,"volume":21225936,"delay":0,"changeRate":-0.00375,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Market Closed","change":-3.557068,"latestTime":"09-11 16:00:00 AEST","open":945.69543,"high":952.96643,"low":941.1126,"amount":229303273,"amplitude":0.012496,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":0,"beginTime":1789344000000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"openAndCloseTimeList":[[1789084800000,1789106400000]],"turnoverRate":0.001482,"increases":6,"decrements":11,"flats":15,"marketCap":232945608954.25,"floatMarketCap":191088125171.5547},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK7501\",,,,,undefined,":{"symbol":"BK7501","high":952.96643,"amplitude":0.012496,"preClose":948.57355,"low":941.1126,"latestPrice":945.0165,"volume":21225936,"delay":0,"open":945.69543,"prevYearClose":900.1661,"prevWeekClose":981.373,"prevMonthClose":977.169,"prevQuarterClose":826.677,"fiveDayClose":981.373,"twentyDayClose":880.437,"sixtyDayClose":803.712,"secType":"PLATE","market":"AU","turnoverRate":0.001482,"marketCap":232945608954.25,"floatMarketCap":191088125171.5547,"timestamp":1789106399882,"nameCN":"Novel Coronavirus Treatment"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK7501\",,,,undefined,":{"bkCode":"BK7501","up":7,"down":9,"flat":17},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK7501\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2664138693","title":"CSL Says Vanguard Group Raises Stake","url":"https://stock-news.laohu8.com/highlight/detail?id=2664138693","media":"MT Newswires Live","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664138693?lang=en_us&edition=fundamental","pubTime":"2026-09-04 11:58","pubTimestamp":1788494293,"startTime":"0","endTime":"0","summary":"CSL (ASX:CSL) said Vanguard Group raised its voting power in the firm to 7.001% as of Aug. 31 from 6% previously, according to a Friday Australian bourse filing.Vanguard holds 33.5 million ordinary shares in the firm as of Aug. 31, per the filing.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["CSL.AU","BK7511","BK7501","BK7067","BK7508"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664238884","title":"Biotron Ltd-Change of Share Registry","url":"https://stock-news.laohu8.com/highlight/detail?id=2664238884","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664238884?lang=en_us&edition=fundamental","pubTime":"2026-09-04 09:08","pubTimestamp":1788484108,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260904:nTUE1TQ5SS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7501","BK7508","BK7067","BIT.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664800459","title":"Dimerix Secures AU$34 Million in Non-Dilutive Loan Facility Agreements; Shares Up 4%","url":"https://stock-news.laohu8.com/highlight/detail?id=2664800459","media":"MT Newswires Live","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664800459?lang=en_us&edition=fundamental","pubTime":"2026-09-04 08:40","pubTimestamp":1788482421,"startTime":"0","endTime":"0","summary":"Dimerix  secured non-dilutive loan facility agreements with a syndicate of Australian and US-based lenders to access up to AU$34 million, according to a Friday Australian bourse filing.This included a previously announced initial facility agreement of AU$10 million with Skiptan, per the filing. The firm confirmed that it was funded through to completion of the Action3 phase 3 trial in DMX-200, as well as the planned phase 2 clinical trial in DMX-652.The facility carries an interest rate of 10% per year, compounding annually, the company said. The receipt of the initial 50% draw-down is anticipated by Sept. 18, and the remainder is expected to take place at the firm's discretion on or before March 31, 2027.The facility provides the flexibility for Dimerix to elect to take further commitments for up to a total of AU$50 million on or before March 31, 2027.The biopharmaceutical company's shares were up 4% in recent Friday trade.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7067","DXB.AU","BK7508","BK7501"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664802749","title":"Dimerix Ltd - Secures A$34 Mln Non-Dilutive Funding Facility","url":"https://stock-news.laohu8.com/highlight/detail?id=2664802749","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664802749?lang=en_us&edition=fundamental","pubTime":"2026-09-04 07:17","pubTimestamp":1788477460,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260903:nFWN44V175:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7508","DXB.AU","BK7501","BK7067"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664433530","title":"Coles cuts ties with controversial CIA-linked US data giantThe US company’s software underpins American deportation raids and battlefield targeting systems.2 min read","url":"https://stock-news.laohu8.com/highlight/detail?id=2664433530","media":"7NEWS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664433530?lang=en_us&edition=fundamental","pubTime":"2026-09-04 00:00","pubTimestamp":1788451200,"startTime":"0","endTime":"0","summary":"Coles has moved to cut ties with controversial US data giant Palantir, whose technology is used by the CIA, the Pentagon and American immigration authorities, after months of public pressure over data","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"7news_stock","url":"https://7news.com.au/news/coles-cuts-ties-with-us-militarylinked-data-giant-palantir-after-privacy-backlash-c-22825780","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://7news.com.au/news/coles-cuts-ties-with-us-militarylinked-data-giant-palantir-after-privacy-backlash-c-22825780","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"7news_stock","symbols":["EYES","PLTY","PLTI","BK4613","BK4585","AIPI","BK4543","IE00B19Z9Z06.USD","BK7040","IGV","IE00B19Z9P08.USD","IE00BZ9MQY76.HKD","BK4547","PLTA","PLYY","PLTZ","PTIR","PLTW","PLTL","PLTR","PLTU","SHLD","GUNZ","PLOO","PLTD","SPLTRmain","BK7501","LU1861559042.SGD","BK4023","PLT","BK4588","IE00B894F039.SGD","BK7082","LU1861558580.USD","COL.AU","PLTG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664282421","title":"Australian Shares Rise as Miners, Banks Gain on Lower Oil, Bond Yields","url":"https://stock-news.laohu8.com/highlight/detail?id=2664282421","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664282421?lang=en_us&edition=fundamental","pubTime":"2026-09-03 15:13","pubTimestamp":1788419596,"startTime":"0","endTime":"0","summary":"Australian shares rise as miners, banks gain on lower oil, bond yieldsSept 3 (Reuters)-Australian shares rebounded from a one-month low on Thursday, led by heavyweight banks, as easing oil prices and ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260903:nL4N44V0E2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CSL.AU","LU0011963245.USD","BHP.AU","LU1430597077.USD","IE00B3M56506.USD","LU0264606111.USD","LU0330918003.SGD","SG9999001143.SGD","RIO.UK","IE00BWDBJ516.SGD","LU0612318385.USD","LU1481600234.SGD","LU0505663152.USD","LU0831103253.SGD","LU0955648018.USD","BK7511","BK7095","LU0075056555.USD","STO.AU","LU0955669360.SGD","BK7007","BK7142","LU0345780950.USD","LU0971552673.USD","LU0345777659.USD","LU0161305163.EUR","LU0266512473.USD","LU1302929846.USD","BK7501","COH.AU","BK7508","LU1064927863.SGD","IE0034235071.USD","LU1130305938.SGD","LU0572939691.SGD","LU0456854461.SGD","LU1046248800.SGD","LU0612318971.USD","LU0345781412.USD","LU0171293334.USD","BK7507","LU0788109121.HKD","LU0654597011.USD","LU0572940350.SGD","LU1078025761.USD","LU0971552830.HKD","BK5111","LU0955623706.USD","BK7067","IE00BQJZX424.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664236888","title":"BCAL Diagnostics - Requests Removal of Michael Aicher and Appointment of Forrester and Melki to Gss Board","url":"https://stock-news.laohu8.com/highlight/detail?id=2664236888","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664236888?lang=en_us&edition=fundamental","pubTime":"2026-09-03 10:40","pubTimestamp":1788403215,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260903:nTUEV0GFX:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7048","BK7501","GSS.AU","BDX.AU","BK7067"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664601823","title":"ASX Penny Stocks To Watch In September 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2664601823","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664601823?lang=en_us&edition=fundamental","pubTime":"2026-09-03 10:04","pubTimestamp":1788401097,"startTime":"0","endTime":"0","summary":"The Australian stock market is poised for a positive start today, with the ASX expected to open higher following a rebound on Wall Street. Amidst this backdrop of fluctuating indices and evolving economic trends, investors are increasingly looking at opportunities in less conventional areas. Though the term 'penny stock' might sound like a relic of past trading days, these smaller or newer companies can still present valuable opportunities when they possess strong financial foundations and...","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-msb/mesoblast-shares/news/asx-penny-stocks-to-watch-in-september-2026-2","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-msb/mesoblast-shares/news/asx-penny-stocks-to-watch-in-september-2026-2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["KSC.AU","BVS.AU","BK7503","BK7058","BK7501","BK7508","MSB.AU","BK7016","BK7067"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664477348","title":"Australia's Coles Falls on Trading Ex-Dividend","url":"https://stock-news.laohu8.com/highlight/detail?id=2664477348","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664477348?lang=en_us&edition=fundamental","pubTime":"2026-09-03 08:45","pubTimestamp":1788396357,"startTime":"0","endTime":"0","summary":"BUZZ-Australia's Coles falls on trading ex-dividend** Shares of ColesCOL.AXdrop as much as 2.3% to A$23.34, their biggest intraday pct drop since July 13** Shares of Australia's no.2 grocer trade ex-dividend, codistributesfinal dividend of 37 Australian cents per share** Shares hit lowest level since Aug 28** Coles weighing on Australian consumer staples sub-index.AXSJ, which is down 0.8%** YTD, COL shares up 9.3%","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260903:nL4N44V01N:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7501","BK7082","BK7040","COL.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664842699","title":"Genetic Signatures - Requested BCAL Diagnostics to Clarify Details of Its Shareholdings and Associates in Gss","url":"https://stock-news.laohu8.com/highlight/detail?id=2664842699","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664842699?lang=en_us&edition=fundamental","pubTime":"2026-09-03 07:38","pubTimestamp":1788392299,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260902:nFWN44U16O:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7067","BK7501","GSS.AU","BDX.AU","BK7048"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664426518","title":"Black Box Warning on CSL's Injectafer Unlikely to Change Much","url":"https://stock-news.laohu8.com/highlight/detail?id=2664426518","media":"Dow Jones","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664426518?lang=en_us&edition=fundamental","pubTime":"2026-09-03 07:34","pubTimestamp":1788392040,"startTime":"0","endTime":"0","summary":"2329 GMT [Dow Jones]--The addition of a black box warning to the label of CSL's Injectafer is unlikely to have a big impact, according to Citi. The Food and Drug Administration approved revised labeling for the iron replacement medicine to warn of the risk of low levels of phosphate in the blood. \"We do not think it will change much,\" says Citi. \"Generics to Injectafer have become available over the last few weeks and, per FDA, are expected to update their labels also.\" Citi has a neutral rating and A$160/share target on CSL. The stock ended Wednesday at A$173.85.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7501","BK7511","BK7067","BK7508","CSL.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664813183","title":"Ansell’s Bigger Buyback And Higher Dividend Could Be A Game Changer For Ansell (ASX:ANN)","url":"https://stock-news.laohu8.com/highlight/detail?id=2664813183","media":"Simply Wall St.","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664813183?lang=en_us&edition=fundamental","pubTime":"2026-09-02 18:27","pubTimestamp":1788344877,"startTime":"0","endTime":"0","summary":"Ansell Limited has completed its A$118.4 million buyback of 3,957,877 shares (2.77% of shares on issue) and, alongside extending its capital management plan to September 6, 2027, reported full-year 2026 sales of US$2,140.2 million and net income of US$208.6 million, while declaring a cash dividend of US$0.415 per share, which went ex-dividend on August 31, 2026.\nThe combination of sharply higher earnings, an increased dividend and ongoing buybacks highlights Ansell’s focus on returning cash...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/6022000-choice1-main-header/1585186795401","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6022000-choice1-main-header/1585186795401"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/healthcare/asx-ann/ansell-shares/news/ansells-bigger-buyback-and-higher-dividend-could-be-a-game-c","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/healthcare/asx-ann/ansell-shares/news/ansells-bigger-buyback-and-higher-dividend-could-be-a-game-c","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK7126","BK4585","BK7501","VIG","ANN.AU","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664975258","title":"Is ResMed (RMD) Below Fair Value On The MatrixCare Sale?","url":"https://stock-news.laohu8.com/highlight/detail?id=2664975258","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664975258?lang=en_us&edition=fundamental","pubTime":"2026-09-02 15:26","pubTimestamp":1788333970,"startTime":"0","endTime":"0","summary":"ResMed (RMD) is back in focus after Frazier Healthcare Partners completed its acquisition of MatrixCare, the company’s residential care software subsidiary, with Jonathan Lujan appointed as MatrixCare’s new chief executive officer.\nResMed’s latest move comes after a mixed year for investors, with the share price down 5.49% year to date but showing a 24.08% 90 day share price return and a 54.84% total shareholder return over three years. However, the one year total shareholder return declined...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/6021000-choice1-main-header/1585186659638","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6021000-choice1-main-header/1585186659638"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/healthcare/nyse-rmd/resmed/news/is-resmed-rmd-below-fair-value-on-the-matrixcare-sale","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/healthcare/nyse-rmd/resmed/news/is-resmed-rmd-below-fair-value-on-the-matrixcare-sale","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["LU2177674079.SGD","BK4082","BK4548","BK7501","IE00B5TLWC47.USD","RMD","BK7007","BK4585","RMD.AU","LU0170899867.USD","BK4504","BK4588","LGHT","LU2008162690.USD","BK4567"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664918898","title":"CSL Bulls Don't See Large Impact from U.S. Pricing Deals","url":"https://stock-news.laohu8.com/highlight/detail?id=2664918898","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664918898?lang=en_us&edition=fundamental","pubTime":"2026-09-02 10:29","pubTimestamp":1788316140,"startTime":"0","endTime":"0","summary":"0229 GMT - CSL's bulls at UBS don't think the Australia-based pharmaceutical company will experience much of a direct financial impact from its U.S. pricing agreements. CSL has agreed to give Medicaid access to medicines at prices comparable to those in other developed economies, but the investment bank's analysts point out that the state-based program accounts for a relatively small part of its U.S. sales. On top of that, they don't see obligations around the pricing of future drug launches as onerous, given that CSL will be in control of settings and able to manage the impact in its best interests. UBS has a last-published buy rating on the stock and a target price of 181.00 Australian dollars. Shares are up 0.5% at A$173.12.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CSL.AU","BK7511","BK7508","BK7067","BK7501"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664864668","title":"Dimerix - Trading Halt Requested Pending Announcement on Non-Dilutive Funding Arrangements","url":"https://stock-news.laohu8.com/highlight/detail?id=2664864668","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664864668?lang=en_us&edition=fundamental","pubTime":"2026-09-02 06:43","pubTimestamp":1788302639,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260901:nFWN44T15S:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7508","BK7067","BK7501","DXB.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664861221","title":"ResMed Launches $450 Million Accelerated Share Buyback With Citibank","url":"https://stock-news.laohu8.com/highlight/detail?id=2664861221","media":"MT Newswires Live","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664861221?lang=en_us&edition=fundamental","pubTime":"2026-09-02 05:54","pubTimestamp":1788299644,"startTime":"0","endTime":"0","summary":"ResMed  said Tuesday it entered into a $450 million accelerated share repurchase agreement with Citigroup's  Citibank, funded with proceeds from the sale of its MatrixCare business and cash on hand.ResMed will pay Citibank $450 million on Thursday and expects an initial share delivery that day equal to 80% of that amount based on the Wednesday closing price. Final settlement is scheduled for December, according to a regulatory filing.The buyback is being conducted under a repurchase authorization for 20 million shares approved by the board in February 2014.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["IYF","LU1074936037.SGD","LU1244550494.USD","LU1791807156.HKD","IE00B5TLWC47.USD","LU0980610538.SGD","LU1144417596.USD","LU0162691827.USD","BK4567","LU0128525689.USD","BK4082","LU1162221912.USD","LU0203345920.USD","RMD","BK7007","LU0170899867.USD","LU2125154935.USD","LU2008162690.USD","LU0106831901.USD","LU1668664300.SGD","BK4566","RMD.AU","LU0098860793.USD","LU2456880835.USD","LU1506573853.SGD","BK4559","LU2236285917.USD","LU2177674079.SGD","LU0130102774.USD","LU0310800965.SGD","LU0320765646.SGD","LU1244550221.USD","CUL3","LGHT","LU0314106906.USD","IE00BSNM7G36.USD","BK4504","TFNS","BK4585","LU1244550577.SGD","BK4548","FTXO","LU0477156953.USD","LU0052756011.USD","LU0203347892.USD","BK7501","LU1201861249.SGD","LU0130517989.USD","BK4588","LU2417539215.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664675118","title":"Here's Why We're Not Too Worried About AnteoTech's (ASX:ADO) Cash Burn Situation","url":"https://stock-news.laohu8.com/highlight/detail?id=2664675118","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664675118?lang=en_us&edition=fundamental","pubTime":"2026-09-02 05:26","pubTimestamp":1788297996,"startTime":"0","endTime":"0","summary":"Just because a business does not make any money, does not mean that the stock will go down. For example, although...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/9551728-choice1-main-header/1585186657000","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/9551728-choice1-main-header/1585186657000"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/materials/asx-ado/anteotech-shares/news/heres-why-were-not-too-worried-about-anteotechs-asxado-cash","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/materials/asx-ado/anteotech-shares/news/heres-why-were-not-too-worried-about-anteotechs-asxado-cash","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK7036","BK7508","BK7501","BK7048","ADO.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664861984","title":"ResMed to Buy Back $450M in Stock Under Accelerated Share Repurchase Agreement","url":"https://stock-news.laohu8.com/highlight/detail?id=2664861984","media":"Dow Jones","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664861984?lang=en_us&edition=fundamental","pubTime":"2026-09-02 05:16","pubTimestamp":1788297360,"startTime":"0","endTime":"0","summary":"ResMed will buy back $450 million of its stock under an accelerated share repurchase agreement with Citibank.The buybacks are being made under a 20 million-share repurchase authorization from 2014, the medical equipment company said in a Tuesday regulatory filing. The purchase will be funded with cash on hand and proceeds from the company's sale of its MatrixCare business.The company said it will make the $450 million payment to Citibank on Thursday, and will receive 80% of that total in stock the same day. The final number of shares will be based on the stock's volume-weighted daily average price during the term of the agreement, which is set to be settled by December.ResMed said it had contemplated the transaction in its full-year guidance issued early last month.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"ResMed to Buy Back $450M in Stock Under Accelerated Share Repurchase Agreement","news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RMD","BK4567","BK7007","BK4585","IE00B5TLWC47.USD","LGHT","LU2008162690.USD","BK4548","RMD.AU","BK4082","BK4588","LU2177674079.SGD","BK7501","LU0170899867.USD","BK4504"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664869597","title":"IDT (IDT) Heads To The Midwest IDEAS Conference, Is It Still 9% Undervalued?","url":"https://stock-news.laohu8.com/highlight/detail?id=2664869597","media":"Simply Wall St.","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664869597?lang=en_us&edition=fundamental","pubTime":"2026-09-02 04:25","pubTimestamp":1788294330,"startTime":"0","endTime":"0","summary":"Conference appearance puts IDT stock in focus\nIDT (IDT) is set to present at the 17th Annual Midwest IDEAS Conference in Chicago on August 26, 2026, an investor-focused event featuring Vice President Bill Ulrey and Chief Financial Officer Marcelo Fischer.\nIDT’s recent share price performance has been firm, with the stock at US$68.22 after a 90 day share price return of 23.12% and a year to date share price return of 34.90%, while the 3 year total shareholder return of 200.05% highlights how...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/9022000-choice1-main-header/1585186680387","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/9022000-choice1-main-header/1585186680387"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/telecom/nyse-idt/idt/news/idt-idt-heads-to-the-midwest-ideas-conference-is-it-still-9","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/telecom/nyse-idt/idt/news/idt-idt-heads-to-the-midwest-ideas-conference-is-it-still-9","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK7501","IDT","BK4115","IDT.AU","BK7096"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664388866","title":"Australia's Consumer Stocks Lag in August Earnings Season, Jefferies Says","url":"https://stock-news.laohu8.com/highlight/detail?id=2664388866","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664388866?lang=en_us&edition=fundamental","pubTime":"2026-09-02 03:28","pubTimestamp":1788290882,"startTime":"0","endTime":"0","summary":"BUZZ-Australia's consumer stocks lag in August earnings season, Jefferies says** Jefferies says Australia's August 2026 earnings season was volatile as expected, with consumer stocks generally underpe","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260901:nL4N44T1PH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7511","DMP.AU","ALD.AU","BK7065","BK7153","HVN.AU","NCK.AU","BK7137","BK7040","BK7041","BK7005","BK7097","BK7107","BK7505","WPR.AU","COL.AU","JBH.AU","BK7070","BK7082","TWE.AU","FLT.AU","WES.AU","BK7501","VEA.AU","EDV.AU","BK7162","BK7001"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":5,"pageCount":2,"totalSize":90,"code":"91000000","status":"200"}]}}